Eliem Therapeutics’ Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement

Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines.Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now